01
Protein structure prediction
The first planned capability: protein folding and complex prediction, with downloadable structures and confidence information.
RESEARCH PILOT · APPROVAL REQUIRED
From sequence to research insight. A planned workspace for molecular predictions, confidence review and reproducible computational biology workflows.
Execution is not yet available. No prediction charges or biological submissions are enabled.

THE RESEARCH WORKFLOW
01
The first planned capability: protein folding and complex prediction, with downloadable structures and confidence information.
02
Future binder-design workflows to generate and evaluate candidates. Laboratory validation remains essential.
03
Future sequence representations for research analysis and downstream bioinformatics workflows.

HUMAN JUDGMENT. COMPUTATIONAL REACH.
Move from a research question to a structured computational experiment. Review model confidence, preserve provenance and decide what deserves laboratory validation.
Find your research workflow ↗BUILT AROUND YOUR RESEARCH
Explore AI protein structure prediction for computational biology and structural biology research. Review confidence information and validate findings experimentally.
Evaluate protein complexes and molecular hypotheses with traceable model versions, project controls and a path to reproducible workflows.
Scope computational protein research around access controls, documented processing regions, provider review and project-level budgets.
Plan structured bioinformatics workflows across approved client projects, with workspace separation and a reviewable job history.
Explore a future protein prediction API integration with job tracking, budget controls and downloadable scientific artifacts. Third-party access requires written approvals.
CONTROL AT EVERY STEP
Planned tenant-level permissions, controlled artifact access and explicit retention settings.
Estimates, spending ceilings and Treasury reconciliation are release requirements. Retail rates are not yet finalized.
Available providers, model licenses and processing regions will be disclosed before any submission. Japan-hosted execution is not EU-only.
START WITH A RESEARCH BRIEF
Prepare your organization, research objective and expected workload. AGICY must approve each client and use case before enabling execution. Resale, third-party API access and material changes of scope require separate written approval.
Prepare pilot brief →Read draft research service terms ↗This is a pilot preview. Provider approval, client approval and technical validation are required before execution becomes available.
A model prediction is a research hypothesis. Confidence metrics are not clinical success probabilities, and laboratory validation is your responsibility.
Boltz2 is the initial evaluation target. The enabled catalogue, model versions, licenses and limits will be confirmed before activation.
Developer access is planned. Serving third parties or reselling access requires AGICY's express prior written approval and any applicable upstream permission.